MedTrace Logo

An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism

NCT00263796 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2014-04-30

No results posted yet for this study

Summary

To study the effect of oxytocin on face processing and response inhibition in autistic adults by fMRI.

Conditions

Interventions

DRUG

Oxytocin

10 international units = 1 cc, IV over 4 hours

DRUG

Placebo

Normal Saline, IV over 4 hours

Sponsors & Collaborators

  • Anagnostou, Evdokia, M.D.

    lead INDIV

Principal Investigators

  • Evdokia Anagnostou, MD · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2010-10-31
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00263796 on ClinicalTrials.gov